CAS 77331-76-1: Propanoic acid,2-methyl-,(9R,10R)-9-(acetyloxy)-9,10-dihydro-8,8-dimethyl-2-oxo-2H,8H-benzo[1,2-b:3,4-b']dipyran-10-ylester

(+)-Hyuganin D is a lignan, a type of natural product derived from plants. It is isolated primarily from the seeds of certain plant species known for their medicinal properties. The mode of action of (+)-Hyuganin D involves the modulation of cellular signaling pathways, particularly those involved in cell growth and apoptosis. This compound exhibits potential anti-cancer activity by inhibiting specific enzymes and interfering with the proliferation of cancer cells. The use of (+)-Hyuganin D extends to various scientific applications, mainly within oncology and pharmacology research. Its ability to influence cell cycle regulation and induce apoptosis in cancer cells makes it a compound of interest in the study of novel therapeutic agents. Additionally, its involvement in modulating oxidative stress pathways opens avenues for exploration in neuroprotection and anti-inflammatory research. While still under investigation, (+)-Hyuganin D represents a promising lead in the development of new drugs targeting complex diseases.

Hyuganin D can inhibit LPS-induced NO and/or TNF-alpha production in mouse peritoneal macrophages.